MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (5)
2015
2014
-
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
Blood, Vol. 123, Núm. 20, pp. 3073-3079
2010
-
Proposals to improve adherence to immunomodulatory therapies in patients with multiple sclerosis
Neurologia, Vol. 25, Núm. 9, pp. 544-551
2007
-
Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis
Blood, Vol. 109, Núm. 10, pp. 4258-4263
1997
-
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors
Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458